Trial intelligence / Profile preview

Carbetocin versus oxytocin for prevention of postpartum hemorrhage in hypertensive pregnant women undergoing elective cesarean section

PACTR201909807831604Completed

Sponsor
Faculty of Medicine, Suez Canal University
Start
Jan 2014
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Trial of carbetocin and oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Faculty of Medicine, Suez Canal University. Primary endpoints: Estimated amount of blood loss, Incidence and amount of blood transfusion and 2 more. Started Jan 2014; status: completed.

02

Drugs

carbetocinoxytocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on PACTR201909807831604.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201909807831604.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call